PLO

Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System

Product code
PLO
Device name
Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System
Device class
Class 2
21 CFR
21 CFR 866.3970
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
4 (all years; only the last 3 years are listed here)

FDA classification definition

A meningitis/encephalitis pathogen multiplex nucleic acid detection system is a qualitative in vitro diagnostic test for the direct detection and identification of microbial-associated nucleic acids in cerebrospinal fluid. The test is indicated for individuals with signs and symptoms of meningitis or encephalitis and aids in diagnosis of agents of meningitis or encephalitis when used in conjunction with clinical and other laboratory findings.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2024-10-29.

NumberDecision dateApplicantDevice nameSummary
K2422562024-10-29QIAGEN GmbHQIAstat-Dx Meningitis/Encephalitis (ME) PanelPDF

1 summaries are archived here for direct download.

Official FDA classification page: PLO
Classification and pathway per current FDA publications. Data from openFDA (CC0).